Primary-source record
status: NOT_YET_RECRUITING → RECRUITING
Summit Therapeutics to Present Ivonescimab Data Across 10 Abstracts at ESMO 2026
Summit Therapeutics opens Phase II SMT112-216 trial of ivonescimab regimens in 1L advanced ccRCC
Summit/Akeso to Present HARMONi-GI1 Ivonescimab Phase 3 BTC Data at ESMO 2026 Presidential Symposium